Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Drug Approved to Treat Smallpox After a Bioterrorist Attack

Aschenbrenner, Diane S., MS, RN

AJN The American Journal of Nursing: November 2018 - Volume 118 - Issue 11 - p 21
doi: 10.1097/01.NAJ.0000547660.47166.0f
Drug Watch
  • A new antiviral drug, tecovirimat (TPOXX), has been approved to treat smallpox. Public health scientists have raised concerns that variola virus, which causes smallpox, could be released in a bioterrorist attack, creating a public health emergency.

Diane S. Aschenbrenner is an assistant professor at Notre Dame of Maryland University in Baltimore. She also coordinates Drug Watch:

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.